Vaginosis, Bacterial Clinical Trial
Official title:
Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial
Bacterial Vaginosis (BV) is a infectious process of the female genitourinary tract, an important health issue due to the high incidence and high rate of recurrence of the infection. Therefore, new therapeutic modalities are sought with the capacity to minimize drug side effects and reduce cases of recurrence of the disease. The objective of this study is to evaluate the clinical and microbiological response of the 401+/- 5nm blue light emitting diode (LED) in the treatment of women with bacterial vaginosis. The group of women with diagnosis of bacterial vaginosis will be submitted to the light therapy. These women will also be submitted to an evaluation and examination by a ginecologist before and after the therapy. There will also be an evaluation of the clinical condition and about the effects of the light through the questionnaire answered before and after participant's treatment. It's expected that the 41 +/- 5nm LED will destroy the VB demonstrated by laboratory examination and also improves the signs and results analyzed by the gynecologist and participants.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 20, 2025 |
Est. primary completion date | December 20, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: • women with 18 to 65 years old and with diagnosis of bacterial vaginosis Exclusion Criteria: • women with injury seen by Pap smear, or in use of pacemaker, with diagnosis or suspicion of neoplasias, with heart diseases, pregnant or with diagnosis of epilepsy |
Country | Name | City | State |
---|---|---|---|
Brazil | Cebtro de Atebçao ao Assolaho Pévico- Escola Bahiana de Medicina e Saúde Pública | Salvador | Bahia |
Lead Sponsor | Collaborator |
---|---|
Centro de Atenção ao Assoalho Pélvico | Salvatore Giovanni Vitale M.D., University of Messina |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Description of types of cells done by oncology and microflora cytology in women treated by blue LED of 401 +/- 5nm | This exam will be done by the collect of vaginal secretion to analyze types of cells and organisms | 15 days | |
Primary | Amount of clue cells quantified by fresh cytology in vaginal secretion of women treated by blu LED of 401 +/- 5nm | This exam will be done by the collect of vaginal secretion using KOH 10% | 10 minutes | |
Primary | Value of vaginal pH measurement in women treated by blue LED | This exam will be done by the collect of vaginal secretion using a pH measuring tape to analyse the hydrogen potential in -log 10 [pH+] in women treated by blue LED. It will be used the numeric scale of pH value | 2 minutes | |
Primary | Identification of bacterial vaginosis by the culture in vaginal secretion of women treated by blue LED | This exam will be done by the collect of vaginal secretion using a Gram exam / culture for bacteria in women treated by blue LED | 15 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02558179 -
Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method
|
N/A | |
Completed |
NCT02314429 -
Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
|
Phase 1 | |
Completed |
NCT02272231 -
Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women
|
||
Completed |
NCT02139839 -
Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14
|
Phase 0 | |
Recruiting |
NCT01448291 -
Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers
|
Phase 4 | |
Completed |
NCT00153517 -
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
|
Phase 2 | |
Completed |
NCT04989543 -
Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)
|
N/A | |
Completed |
NCT02641717 -
Validity of Patient-Collected Wet Mounts
|
N/A | |
Terminated |
NCT03943823 -
Postmenopausal Pessary Users: Estrogen Versus Trimosan
|
Phase 4 | |
Completed |
NCT03134924 -
Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention "WASH-2"
|
N/A | |
Completed |
NCT01293643 -
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)
|
Phase 3 | |
Terminated |
NCT01153958 -
Colposeptine for the Treatment of Bacterial Vaginosis
|
Phase 4 | |
Completed |
NCT00484653 -
Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman
|
N/A | |
Completed |
NCT05649735 -
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS
|
N/A | |
Completed |
NCT02860845 -
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
|
Phase 4 | |
Not yet recruiting |
NCT00491270 -
Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
|
Phase 3 | |
Completed |
NCT01055106 -
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
|
Phase 2 | |
Terminated |
NCT01322971 -
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
|
N/A | |
Completed |
NCT04171947 -
Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment
|
N/A | |
Completed |
NCT02392026 -
Safety and Tolerability of Metronidazole Gel 1.3%
|
Phase 4 |